info@invisionmedi.com
V-BOSE-M2 Tablets
Obtain Supercilious Glycemic Control
COMPOSITION – Voglibose IP 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)
Description
- In a 24-week study on Korean patients with Type 2 DM and with inadequate glycemic control on diet and exercise, treatment with voglibose and metformin provided superior glycemic control for HbA1c, 2h-PPG, and FPG levels, greater weight loss, and less glycemic variability than did metformin monotherapy.
Composition
- Voglibose IP 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)